Clinical Trial Update: Paclitaxel in Treating Patients With Locally Advanced or Metastatic Soft Tissue Angiosarcoma or Lymphangiosarcoma That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating paclitaxel for locally advanced or metastatic soft tissue angiosarcoma or lymphangiosarcoma that cannot be removed surgically.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angiosarcoma
• Lymphangiosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: UNICANCER | Conditions: Sarcoma | Phase 2 | Status: COMPLETED